Hikma Pharmaceuticals (HIKL)

1,658.00p
   
  • Change Today:
      0.25p
  • 52 Week High: 1,857.00
  • 52 Week Low: 1,195.00
  • Currency: UK Pounds
  • Shares Issued: 199.39m
  • Volume: 98,601
  • Market Cap: £3,305.81m

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Jun-26 Interim 1,728.00 287.00 103.00¢ 38.00¢

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 2,553.00 544.00 194.80¢ 15.4 1.2 +13% 54.00¢ 1.8%
31-Dec-22 2,517.00 233.00 181.00¢ 11.6 n/a -7% 56.00¢ 2.7%
31-Dec-23 2,875.00 281.00 223.00¢ 10.8 0.5 +23% 72.00¢ 3.0%
31-Dec-24 3,127.00 455.00 224.00¢ 12.1 n/a 0% 80.00¢ 3.0%
31-Dec-25 3,349.00 519.00 228.00¢ 9.2 4.6 +2% 84.00¢ 4.0%

Forecasts

Forecasts data is not available for this company.

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 15.34 9.18 11.25 0.82

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

HIKL Market Data

Currency UK Pounds
Share Price 1,658.00p
Change Today 0.25p
% Change 1.50 %
52 Week High 1,857.00
52 Week Low 1,195.00
Volume 98,601
Shares Issued 199.39m
Market Cap £3,305.81m

Trades for 18-Aug-2026

Time Volume / Share Price
16:29 3 @ 1,658.00p
16:29 85 @ 1,658.00p
16:29 50 @ 1,657.00p
16:29 24 @ 1,657.00p
16:29 4 @ 1,657.00p

HIKL Key Personnel

CEO Said Darwazah
Chair Victoria Hull

Top of Page